$MEIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MEI Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MEI Pharma, Inc.. Get notifications about new insider transactions in MEI Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 7.43 | 6,730 | 50,004 | 18,924 | |
Jul 17 2013 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 7.43 | 6,730 | 50,004 | 10,793 | |
Jul 02 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 7.58 | 426 | 3,228 | 231,216 | 231.6 K to 231.2 K (-0.18 %) |
Jul 02 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 7.58 | 7,337 | 55,598 | 3,979,758 | 4 M to 4 M (-0.18 %) |
Jun 13 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 7.80 | 236,273 | 1,842,929 | 3,987,095 | 4.2 M to 4 M (-5.59 %) |
Jun 13 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 7.80 | 13,727 | 107,071 | 231,642 | 245.4 K to 231.6 K (-5.59 %) |
Jun 11 2013 | MEIP | MEI Pharma, Inc. | Glover Nicholas | Director | Option Exercise | A | 8.09 | 4,063 | 32,870 | 4,063 | |
May 20 2013 | MEIP | MEI Pharma, Inc. | Vivo Ventures V, LLC | 10% Owner | Sell | S | 9.07 | 1,012 | 9,174 | 245,369 | 246.4 K to 245.4 K (-0.41 %) |
May 20 2013 | MEIP | MEI Pharma, Inc. | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 9.07 | 17,428 | 157,994 | 4,223,368 | 4.2 M to 4.2 M (-0.41 %) |
May 08 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 8.45 | 100,000 | 845,000 | 2,045,475 | 2.1 M to 2 M (-4.66 %) |
May 08 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 8.70 | 100,000 | 870,000 | 2,145,475 | 2.2 M to 2.1 M (-4.45 %) |
Apr 22 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 8.43 | 157,300 | 1,326,039 | 2,245,475 | 2.4 M to 2.2 M (-6.55 %) |
Apr 22 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 8.57 | 100,000 | 857,000 | 2,402,775 | 2.5 M to 2.4 M (-4.00 %) |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 8.63 | 4,032 | 34,796 | 12,194 | |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 8.63 | 4,032 | 34,796 | 12,194 | |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 8.63 | 68,330 | 589,688 | 136,659 | |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 8.63 | 4,032 | 34,796 | 12,194 | |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 8.63 | 4,032 | 34,796 | 12,194 | |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 | |
Apr 02 2013 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 8.63 | 81,835 | 706,236 | 111,000 | |
Feb 20 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 6.80 | 300,000 | 2,040,000 | 2,502,775 | 2.8 M to 2.5 M (-10.70 %) |
Feb 20 2013 | MEIP | MEI Pharma, Inc. | New Leaf Ventures II, L.P. | 10% Owner | Sell | S | 6.60 | 197,225 | 1,301,685 | 2,802,775 | 3 M to 2.8 M (-6.57 %) |
Feb 11 2013 | MEIP | MEI Pharma, Inc. | Reynolds Thomas C | Director | Option Exercise | A | 5.19 | 6,319 | 32,796 | 6,319 | |
Jan 29 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 5.90 | 5,920 | 34,928 | 17,000 | 11.1 K to 17 K (+53.43 %) |
Jan 29 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 5.75 | 80 | 460 | 11,080 | 11 K to 11.1 K (+0.73 %) |
Jan 29 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 6.25 | 4,200 | 26,250 | 11,000 | 6.8 K to 11 K (+61.76 %) |
Jan 28 2013 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 6.25 | 800 | 5,000 | 6,800 | 6 K to 6.8 K (+13.33 %) |
Dec 26 2012 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 7.17 | 1,700 | 12,183 | 6,000 | 4.3 K to 6 K (+39.53 %) |
Dec 26 2012 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 7.19 | 1,800 | 12,940 | 4,300 | 2.5 K to 4.3 K (+72.00 %) |
Dec 11 2012 | MEIP | MEI Pharma, Inc. | AUSTIN JOSIAH T | 10% Owner | Option Exercise | J | 1.19 | 1,000,000 | 1,190,000 | 1,000,000 | |
Dec 10 2012 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | J | 1.19 | 2,988,672 | 3,556,520 | 2,989,380 | |
Dec 05 2012 | MEIP | MEI Pharma, Inc. | AUSTIN JOSIAH T | 10% Owner | Buy | J | 0.00 | 3,478,245 | 0 | 3,832,081 | 353.8 K to 3.8 M (+983.01 %) |
Dec 05 2012 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Sell | J | 0.00 | 17,837,246 | 0 | 0 | 17.8 M to 0 (-100.00 %) |
Nov 21 2012 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Option Exercise | C | 0.00 | 1,000 | 0 | 0 | |
Nov 21 2012 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Buy | C | 0.00 | 4,827,000 | 0 | 17,837,246 | 13 M to 17.8 M (+37.10 %) |
Nov 20 2012 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 1.42 | 300,000 | 426,000 | 720,390 | |
Sep 25 2012 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 0.71 | 23,810 | 16,905 | 48,979 | |
Sep 25 2012 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 0.71 | 23,810 | 16,905 | 48,979 | |
Sep 25 2012 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 0.71 | 23,810 | 16,905 | 48,979 | |
Sep 25 2012 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 0.71 | 23,810 | 16,905 | 48,979 | |
Sep 25 2012 | MEIP | MEI Pharma, Inc. | Williams Bryan | Director | Option Exercise | A | 0.71 | 23,810 | 16,905 | 48,979 | |
Aug 09 2012 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 0.46 | 100,000 | 46,000 | 420,390 | |
Aug 09 2012 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 0.46 | 232,359 | 106,885 | 409,979 | |
Aug 09 2012 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 0.46 | 75,000 | 34,500 | 175,000 | |
Jul 09 2012 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Buy | P | 0.43 | 15,000 | 6,431 | 15,000 | 0 to 15 K |
May 15 2012 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Option Exercise | X | 1.19 | 2,247,168 | 2,674,130 | 2,247,168 | |
May 15 2012 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Option Exercise | X | 0.45 | 8,988,675 | 3,999,960 | 0 | |
May 15 2012 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Buy | X | 0.89 | 4,494,377 | 3,999,996 | 17,837,286 | 13.3 M to 17.8 M (+33.68 %) |
May 15 2012 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | X | 1.19 | 708 | 843 | 708 | |
May 15 2012 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | X | 0.45 | 2,834 | 1,261 | 0 | |
May 15 2012 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Buy | X | 0.89 | 1,417 | 1,261 | 3,501 | 2.1 K to 3.5 K (+67.99 %) |
May 15 2012 | MEIP | MEI Pharma, Inc. | Williams Bryan | Director | Option Exercise | X | 1.19 | 125 | 149 | 125 | |
May 15 2012 | MEIP | MEI Pharma, Inc. | Williams Bryan | Director | Option Exercise | X | 0.45 | 500 | 223 | 0 | |
May 15 2012 | MEIP | MEI Pharma, Inc. | Williams Bryan | Director | Buy | X | 0.89 | 250 | 223 | 750 | 500 to 750 (+50.00 %) |
Oct 24 2011 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Option Exercise | A | 1.34 | 25,169 | 33,726 | 25,169 | |
Dec 30 2011 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Grant | A | 1.03 | 1,941,747 | 1,999,999 | 13,342,909 | 11.4 M to 13.3 M (+17.03 %) |
Oct 24 2011 | MEIP | MEI Pharma, Inc. | Williams Bryan | Director | Option Exercise | A | 1.34 | 25,169 | 33,726 | 25,169 | |
Oct 24 2011 | MEIP | MEI Pharma, Inc. | White Christine Anna | Director | Option Exercise | A | 1.34 | 25,169 | 33,726 | 25,169 | |
Oct 24 2011 | MEIP | MEI Pharma, Inc. | Cann Leah Rush | Director | Option Exercise | A | 1.34 | 25,169 | 33,726 | 25,169 | |
Oct 05 2011 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Grant | A | 1.50 | 1,333,333 | 2,000,000 | 11,401,162 | 10.1 M to 11.4 M (+13.24 %) |
Oct 24 2011 | MEIP | MEI Pharma, Inc. | Baltic Charles V. III | Director | Option Exercise | A | 1.34 | 25,169 | 33,726 | 25,169 | |
Aug 03 2011 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | Chief Executive Off ... | Option Exercise | A | 1.90 | 100,000 | 190,000 | 320,390 | |
Aug 03 2011 | MEIP | MEI Pharma, Inc. | Zech Thomas M. | Chief Financial Off ... | Option Exercise | A | 1.90 | 26,537 | 50,420 | 100,000 | |
Jun 03 2011 | MEIP | MEI Pharma, Inc. | Mass Robert D. | Chief Medical Offic ... | Option Exercise | A | 1.28 | 177,620 | 227,354 | 177,620 | |
May 10 2011 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Option Exercise | P | 0.00 | 1,000 | 0 | 1,000 | |
Sep 24 2010 | MEIP | MEI Pharma, Inc. | GOLD DANIEL P PHD | President and Chief ... | Option Exercise | A | 1.89 | 110,195 | 208,269 | 220,390 | |
Sep 08 2009 | MEIP | MEI Pharma, Inc. | JOHNSTON PHILIP A | Director | Buy | P | 0.55 | 10,000 | 5,500 | 10,000 | 0 to 10 K |
Nov 24 2008 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Buy | P | 0.50 | 849 | 425 | 20,849 | 20 K to 20.8 K (+4.25 %) |
Nov 20 2008 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Buy | P | 0.84 | 10,000 | 8,366 | 20,000 | 10 K to 20 K (+100.00 %) |
Sep 24 2008 | MEIP | MEI Pharma, Inc. | Williams Bryan | Director | Buy | P | 2.52 | 5,000 | 12,600 | 5,000 | 0 to 5 K |
Jul 30 2008 | MEIP | MEI Pharma, Inc. | NOVOGEN LTD | 10% Owner | Buy | P | 2.17 | 2,908,295 | 6,311,000 | 52,408,295 | 49.5 M to 52.4 M (+5.88 %) |
Mar 18 2008 | MEIP | MEI Pharma, Inc. | SEATON DAVID R | CFO & Secretary | Buy | P | 2.20 | 5,000 | 11,000 | 5,000 | 0 to 5 K |
Mar 17 2008 | MEIP | MEI Pharma, Inc. | NAUGHTON CHRISTOPHER | CEO & President | Buy | P | 2.40 | 3,600 | 8,640 | 5,000 | 1.4 K to 5 K (+257.14 %) |
Mar 17 2008 | MEIP | MEI Pharma, Inc. | NAUGHTON CHRISTOPHER | CEO & President | Buy | P | 2.40 | 1,400 | 3,360 | 1,400 | 0 to 1.4 K |
Mar 11 2008 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Buy | P | 2.25 | 9,771 | 21,985 | 1,000 | -8,771 to 1,000 (-111.40 %) |
Mar 11 2008 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Buy | P | 2.20 | 229 | 504 | 229 | 0 to 229 |
Mar 11 2008 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Sell | S | 2.50 | 989 | 2,473 | 0 | 989 to 0 (-100.00 %) |
Mar 11 2008 | MEIP | MEI Pharma, Inc. | Rueckert William Dodge | Director | Sell | S | 2.40 | 11 | 26 | 989 | 1,000 to 989 (-1.10 %) |